- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05320965
Prospective Validation of the Model Predicting Postoperative Delirium Occurrence With Machine Learning-based Analysis of Intraoperative Biological Signals During Anesthesia in Cardiac Surgery
April 3, 2022 updated by: Yonsei University
Postoperative delirium (POD) not only increases the length of hospitalization and intensive care unit stay and medical costs, but is also closely associated with negative prognosis, including postoperative mortality, increased morbidity, long-term cognitive decline after surgery, and impaired quality of life and independence.
The preoperative risk assessment and early detection of POD are very important in the proper management of POD.
This is because drug treatment that can prevent or treat POD is limited, and for its prevention and management, a multidisciplinary approach and resource management covering almost all aspects of patient management are required.
Therefore, if there is a model that can predict the occurrence of POD, it can be of great help in managing delirium after cardiac surgery through more accurate risk assessment and early detection.
In previous studies, aging and cognitive decline before surgery are known as major risk factors for POD, but identification of risk factors before surgery alone is insufficient to predict the occurrence of POD.
Cardiac surgery is highly likely to cause pathophysiological changes that can cause POD, because it is associated with hemodynamic instability, cardiopulmonary use, changes in body temperature, and systemic inflammatory response.
These pathophysiological changes can be reflected in the data (biosignals) obtained through various monitoring devices during anesthesia.
Most of the events that occur during anesthesia are considered to be correctable risk factors of POD, unlike preoperative risk factors, and there is a potential to reduce the occurrence of POD by actively correcting them.
Therefore, it is necessary to analyze the effect of these intraoperative biosignals on POD.
In the delirium prediction model development process, rather than simply dividing the already collected data and using it in the model performance validation process, it is better to conduct model performance validation based on patient data prospectively collected to prevent overfitting and achieve higher predictive performance.
Therefore, this study aims to collect prospective data to evaluate the performance of the delirium prediction model after cardiac surgery built using machine learning techniques based on the already collected data including biosignals during anesthesia.
After reviewing the medical records from the day of surgery to the period of stay in the ICU, if the Intensive Care Delirium Screening Checklist (ICDSC) score is 6 or higher or there is a record of consultation with delirium, it is recorded as POD.
After structuring the database through purification, standardization, outlier detection, and sampling of biosignal data generated during surgery, various variables obtained from medical records are collected to construct an evaluation dataset.
Using this dataset, the performance of the delirium prediction model built by applying the machine learning algorithm is evaluated through Receiver Operating Characteristic curve analysis.
Study Overview
Status
Active, not recruiting
Conditions
Study Type
Observational
Enrollment (Anticipated)
200
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Seoul, Korea, Republic of
- Yonsei University Health System, Severance Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
19 years to 100 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Adult patients scheduled for heart/aorta surgery at a tertiary hospital
Description
Inclusion Criteria:
- Adults between 19 and 100 years of age
- Patients scheduled for cardiac or aortic surgery
Exclusion Criteria:
- Patients with a history of major neurocognitive disorder, major depressive disorder, and alcohol or drug dependence before surgery
- Patients who have already lost consciousness before surgery
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Postoperative delirium
Time Frame: up to 7 days post-surgery
|
The Intensive Care Delirium Screening Checklist (ICDSC) score is 6 or higher
|
up to 7 days post-surgery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Sarah Soh, MD. PhD., Department of Anesthesiology and Pain Medicine, Yonsei Cardiovascular Hospital, Yonsei University College of Medicine
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 17, 2022
Primary Completion (Anticipated)
December 31, 2023
Study Completion (Anticipated)
February 29, 2024
Study Registration Dates
First Submitted
April 3, 2022
First Submitted That Met QC Criteria
April 3, 2022
First Posted (Actual)
April 11, 2022
Study Record Updates
Last Update Posted (Actual)
April 11, 2022
Last Update Submitted That Met QC Criteria
April 3, 2022
Last Verified
April 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 4-2022-0093
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Adult Patients Undergoing Open Heart Surgery
-
Shaare Zedek Medical CenterUnknownPatients Undergoing Open Heart Surgery | Patients Undergoing Lung SurgeryIsrael
-
West China HospitalSichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital... and other collaboratorsNot yet recruitingPatients Undergoing Open Thyroid SurgeryChina
-
West China HospitalSichuan Provincial People's Hospital; West China Tianfu Hospital; Shang Jin Hospital... and other collaboratorsCompletedPatients Undergoing Open Thyroid SurgeryChina
-
Yonsei UniversityCompletedAdult Patients Undergoing Surgery That Requires General AnesthesiaKorea, Republic of
-
Yonsei UniversityUnknownPatients Undergoing Valvular Heart SurgeryKorea, Republic of
-
Ankara City Hospital BilkentCompletedUndergoing Open-Heart SurgeryTurkey
-
University of PecsCompletedOpen Heart Surgery PatientsHungary
-
Betul Zeynep YildizEnrolling by invitation
-
Xijing HospitalRecruitingAdult Patients Undergoing CABGChina
-
Indonesia UniversityCompletedAdult Patients Undergoing ERCPIndonesia